Biotech Archives - Page 698 of 795

2 minute read

FDA Okays bluebird bio’s $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know

September 17, 9:46 AM

Biotechnology company, bluebird bio, Inc. (NASDAQ: BLUE) announced late Friday that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.

BLUE

3 minute read

Heron Therapeutics Announces U.S. FDA Approval Of APONVIE For The Prevention Of Postoperative Nausea And Vomiting

By Benzinga Newsdesk

September 16, 2:51 PM

- APONVIE is the first and only intravenous (IV) formulation of a substance P/neurokinin-1 (NK1) receptor antagonist indicated for PONV - - Delivered via a single 30-second IV injection, APONVIE has demonstrated rapid achievement of therapeutic drug levels ideally suited for the surgical setting -

HRTX

1 minute read

Recent Selloff Is A ‘Buying Opportunity’ For This NASH Stock, Says Analyst

By Vandana Singh

September 16, 2:05 PM

Yesterday, Altimmune Inc (NASDAQ:ALT) announced results from a Phase 1b trial evaluating pemvidutide (ALT-801), a novel glucagonlike peptide-1 (GLP-1) and glucagon dual…

ALT

1 minute read

Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report

By Vandana Singh

September 16, 1:55 PM

Citing the Initiative for Medicines, Access & Knowledge’s (I-MAK) report, Reuters said that several makers of top-selling drugs…

ABBV

1 minute read

FDA Updating: April 27 Letter To Health Care Providers Regarding Certain Medtronic Electromyogram Endotracheal Tubes, Risk Of Airway Obstruction; To Ensure Health Care Providers In The Operating Room Setting Are Aware Of The Voluntary Recall Initiated…

By Benzinga Newsdesk

September 16, 1:13 PM

- Reuters

MDT

2 minute read

Earlier Announced: China Records First Monkeypox Case

By Benzinga Newsdesk

September 16, 10:51 AM

https://www.scmp.com/news/china/science/article/3192823/china-records-first-monkeypox-case?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=1663339580 The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine

AEMD

1 minute read

India Globalization Capita Just Got FDA Approval To Start Enrolling Their Phase 2 Alzheimer Trial With IGC-AD1, A Cannabis Drug

By Benzinga Newsdesk

September 16, 10:49 AM

https://clinicaltrials.gov/ct2/show/NCT05543681 Brief Summary: This is a superiority, parallel group, double blinded, randomized, powered, multi-site, and placebo-controlled study. Ages 60 and above

IGC

2 minute read

Quince Therapeutics Presents Preclinical Data At MHSRS 2022 Demonstrating Preclinical Efficacy Of Bone-targeting Platform For Traumatic Bone Injury

By Benzinga Newsdesk

September 16, 8:05 AM

Quince Therapeutics, Inc. (NASDAQ:QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, today detailed highlights from the company's participation at

QNCX

1 minute read

Amry Announced CHMP Adopts Positive Opinion for Mycapssa for the Treatment of Acromegaly

By Charles Gross

September 16, 7:32 AM

Amryt (Nasdaq: AMYT) is pleased to announce that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the approval of Mycapssa® in the European Union (EU) for the maintenance treatment of acromegaly in patients who have responded to and to

AMYT

1 minute read

UPDATE: ‘Interim data from the cardiomyopathy arm of the Phase 1 study of NTLA-2001 showed deep and sustained mean serum transthyretin (TTR) reductions of 93% and 92% at 0.7 mg/kg and 1.0 mg/kg doses, respectively, at day 28’

By Bill Haddad

September 16, 7:16 AM

CAMBRIDGE, Mass. and TARRYTOWN, N.Y., Sept. 16, 2022 /PRNewswire/ -- Intellia Therapeutics, Inc. (NASDAQ: NTLA) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced positive interim

NTLA